FI885543A - Dna-segment, polypeptider och anti-kroppar anslutande till human vaevnadsfaktor. - Google Patents
Dna-segment, polypeptider och anti-kroppar anslutande till human vaevnadsfaktor. Download PDFInfo
- Publication number
- FI885543A FI885543A FI885543A FI885543A FI885543A FI 885543 A FI885543 A FI 885543A FI 885543 A FI885543 A FI 885543A FI 885543 A FI885543 A FI 885543A FI 885543 A FI885543 A FI 885543A
- Authority
- FI
- Finland
- Prior art keywords
- vaevnadsfaktor
- croppar
- anslutande
- polypeptider
- oti
- Prior art date
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/86—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood coagulating time or factors, or their receptors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H21/00—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/745—Blood coagulation or fibrinolysis factors
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/36—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against blood coagulation factors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/745—Assays involving non-enzymic blood coagulation factors
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
- Y10S530/808—Materials and products related to genetic engineering or hybrid or fused cell technology, e.g. hybridoma, monoclonal products
- Y10S530/809—Fused cells, e.g. hybridoma
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FI954347A FI97813C (fi) | 1987-03-31 | 1995-09-15 | Monoklonaaliset vasta-ainekoostumukset ja monoklonaalisia vasta-aineita tuottavat hybridomat |
Applications Claiming Priority (8)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US3304787A | 1987-03-31 | 1987-03-31 | |
US3304787 | 1987-03-31 | ||
US07/067,103 US5110730A (en) | 1987-03-31 | 1987-06-25 | Human tissue factor related DNA segments |
US6710387 | 1987-06-25 | ||
US07/165,939 US5223427A (en) | 1987-03-31 | 1988-03-09 | Hybridomas producing monoclonal antibodies reactive with human tissue-factor glycoprotein heavy chain |
US16593988 | 1988-03-09 | ||
US8800998 | 1988-03-29 | ||
PCT/US1988/000998 WO1988007543A1 (en) | 1987-03-31 | 1988-03-29 | Human tissue factor related dna segments, polypeptides and antibodies |
Publications (3)
Publication Number | Publication Date |
---|---|
FI885543A true FI885543A (fi) | 1988-11-29 |
FI885543A0 FI885543A0 (fi) | 1988-11-29 |
FI100184B FI100184B (fi) | 1997-10-15 |
Family
ID=27364291
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FI885543A FI100184B (fi) | 1987-03-31 | 1988-11-29 | Ihmisen kudostekijään liittyvä DNA-kappale ja yhdistelmä-DNA-molekyyli sekä menetelmä proteiinin valmistamiseksi |
FI954347A FI97813C (fi) | 1987-03-31 | 1995-09-15 | Monoklonaaliset vasta-ainekoostumukset ja monoklonaalisia vasta-aineita tuottavat hybridomat |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FI954347A FI97813C (fi) | 1987-03-31 | 1995-09-15 | Monoklonaaliset vasta-ainekoostumukset ja monoklonaalisia vasta-aineita tuottavat hybridomat |
Country Status (13)
Country | Link |
---|---|
US (2) | US5223427A (fi) |
EP (2) | EP0309548B1 (fi) |
JP (1) | JP2809415B2 (fi) |
AT (1) | ATE246200T1 (fi) |
AU (1) | AU605864B2 (fi) |
CA (1) | CA1340544C (fi) |
DE (1) | DE3856560T2 (fi) |
DK (1) | DK175703B1 (fi) |
ES (1) | ES2009590A6 (fi) |
FI (2) | FI100184B (fi) |
NO (1) | NO305211B1 (fi) |
PT (1) | PT87138B (fi) |
WO (1) | WO1988007543A1 (fi) |
Families Citing this family (82)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7084251B1 (en) | 1987-02-12 | 2006-08-01 | Genentech, Inc. | Methods and Deoxyribonucleic acid for the preparation of tissue factor protein |
US6994988B1 (en) | 1987-02-12 | 2006-02-07 | Genetech, Inc. | Methods and deoxyribonucleic acid for the preparation of tissue factor protein |
US6001978A (en) * | 1987-03-31 | 1999-12-14 | The Scripps Research Institute | Human tissue factor related DNA segments polypeptides and antibodies |
IL87172A (en) * | 1987-07-23 | 1994-12-29 | Univ Washington | A method of inhibiting the isolation of a purer tissue factor |
NO892506L (no) * | 1988-06-17 | 1989-12-18 | Sinai School Medicine | Kloning og ekspresjon av human vevsfaktor. |
US5472850A (en) * | 1991-04-10 | 1995-12-05 | Oklahoma Medical Research Foundation | Quantitative clotting assay for activated factor VII |
US5298599A (en) * | 1988-12-30 | 1994-03-29 | Oklahoma Medical Research Foundation | Expression and purification of recombinant soluble tissue factor |
US6203816B1 (en) * | 1990-11-13 | 2001-03-20 | Corvas International, Inc. | Tissue factor based prothrombin time reagent |
US5314695A (en) † | 1990-11-13 | 1994-05-24 | Corvas International, Inc. | Tissue factor based prothrombin time reagent |
CA2077906A1 (en) * | 1991-01-10 | 1992-07-11 | Kimihiko Matsuzawa | Method for measurement of tissue factor in high sensitivity and measurement kit therefor |
US5374617A (en) * | 1992-05-13 | 1994-12-20 | Oklahoma Medical Research Foundation | Treatment of bleeding with modified tissue factor in combination with FVIIa |
US5504064A (en) * | 1991-04-10 | 1996-04-02 | Oklahoma Medical Research Foundation | Treatment of bleeding with modified tissue factor in combination with an activator of FVII |
US6004555A (en) * | 1992-03-05 | 1999-12-21 | Board Of Regents, The University Of Texas System | Methods for the specific coagulation of vasculature |
US6093399A (en) * | 1992-03-05 | 2000-07-25 | Board Of Regents, The University Of Texas System | Methods and compositions for the specific coagulation of vasculature |
US5877289A (en) * | 1992-03-05 | 1999-03-02 | The Scripps Research Institute | Tissue factor compositions and ligands for the specific coagulation of vasculature |
US6036955A (en) * | 1992-03-05 | 2000-03-14 | The Scripps Research Institute | Kits and methods for the specific coagulation of vasculature |
US6749853B1 (en) * | 1992-03-05 | 2004-06-15 | Board Of Regents, The University Of Texas System | Combined methods and compositions for coagulation and tumor treatment |
US6063764A (en) * | 1992-06-01 | 2000-05-16 | Washington University & Chiron Corp. | Method for using lipoprotein associated coagulation inhibitor to treat sepsis |
US20030171292A1 (en) * | 1992-06-01 | 2003-09-11 | Creasey Abla A. | Method for using lipoprotein associated coagulation inhibitor to treat sepsis |
US5879677A (en) * | 1992-12-09 | 1999-03-09 | The Scripps Research Institute | Method for inhibition of cerebral tissue factor mediated reperfusion damage |
US20010048924A1 (en) * | 1998-06-22 | 2001-12-06 | Del Zoppo Gregory J. | Method for inhibiting cerebral tissue factor mediated reperfusion damage |
CA2180140A1 (en) * | 1993-12-27 | 1995-07-06 | Jeffrey I. Weitz | Methods and compositions for inhibiting thrombogenesis |
DK0833911T3 (da) * | 1995-06-07 | 2004-08-30 | Ortho Mcneil Pharm Inc | CDR-transplanterede anti-vævsfaktorantistoffer og fremgangsmåder til anvendelse deraf |
US5837684A (en) * | 1995-06-07 | 1998-11-17 | Nycomed Imaging As | Peptides |
US6379975B1 (en) | 1996-11-27 | 2002-04-30 | T.A.C. Thrombosis And Coagulation Aktiebolag | Methods and reagents for determining protein S |
ATE244579T1 (de) * | 1997-01-22 | 2003-07-15 | Univ Texas | Verfahren und zusammensetzungen des gewebefaktors zur koagulation und behandlung von tumoren |
US20030109680A1 (en) * | 2001-11-21 | 2003-06-12 | Sunol Molecular Corporation | Antibodies for inhibiting blood coagulation and methods of use thereof |
US20060235209A9 (en) * | 1997-03-10 | 2006-10-19 | Jin-An Jiao | Use of anti-tissue factor antibodies for treating thromboses |
US20040229282A1 (en) * | 1997-03-10 | 2004-11-18 | Sunol Molecular Corporation | Antibodies for inhibiting blood coagulation and methods of use thereof |
US5986065A (en) * | 1997-03-10 | 1999-11-16 | Sunol Molecular Corporation | Antibodies for inhibiting blood coagulation and methods of use thereof |
US7749498B2 (en) * | 1997-03-10 | 2010-07-06 | Genentech, Inc. | Antibodies for inhibiting blood coagulation and methods of use thereof |
WO1998048283A1 (en) * | 1997-04-23 | 1998-10-29 | Instrumentation Laboratory S.P.A. | Recombinant rabbit tissue factor based prothrombin time reagent |
ES2364266T3 (es) * | 1998-04-03 | 2011-08-30 | Chugai Seiyaku Kabushiki Kaisha | Anticuerpo humanizado hacia el factor tisular humano (tf) y procedimiento para construir el anticuerpo humanizado. |
BR9912053A (pt) | 1998-07-13 | 2001-04-03 | Univ Texas | Processos de tratamento de câncer utilizando conjugados terapêuticos que se ligam a aminofosfolipìdios |
US6818213B1 (en) | 1998-07-13 | 2004-11-16 | Board Of Regents, The University Of Texas System | Cancer treatment compositions comprising therapeutic conjugates that bind to aminophospholipids |
CA2335274A1 (en) | 1998-07-15 | 2000-01-27 | Genentech, Inc. | Tissue factor protein variants with increased affinity for coagulation factor fvii/fviia |
US7764130B2 (en) * | 1999-01-22 | 2010-07-27 | Multigig Inc. | Electronic circuitry |
EP2351483A1 (en) * | 1999-10-01 | 2011-08-03 | Chugai Seiyaku Kabushiki Kaisha | Prevention and treatment of blood coagulation-related diseases |
JP2003518075A (ja) | 1999-12-24 | 2003-06-03 | ジェネンテック・インコーポレーテッド | 生理活性化合物の消失半減期延長のための方法及び組成物 |
US6703494B2 (en) * | 2000-03-16 | 2004-03-09 | Genentech, Inc. | Anti-tissue factor antibodies with enhanced anticoagulant potency |
US6855509B2 (en) * | 2000-12-19 | 2005-02-15 | Instrumentation Laboratory Company | Protein S functional assay and kit therefor |
US20030143225A1 (en) * | 2001-03-08 | 2003-07-31 | Genentech, Inc. | Combinations of anti-tissue factor antibodies and anticoagulant and/or antiplatelet agents |
US20030129193A1 (en) * | 2001-09-27 | 2003-07-10 | Board Of Regents, The University Of Texas System And Peregrine Pharmaceuticals, Inc. | Combined methods for tumor vasculature coaguligand treatment |
CN1575302A (zh) * | 2001-10-02 | 2005-02-02 | 诺沃挪第克公司 | 人组织因子抗体 |
PL372138A1 (en) * | 2001-10-15 | 2005-07-11 | Chiron Corporation | Treatment of sepsis by low dose administration of tissue factor pathway inhibitor (tfpi) |
US7399743B2 (en) * | 2001-10-26 | 2008-07-15 | The Scripps Research Institute | Targeted thrombosis |
US20030190705A1 (en) * | 2001-10-29 | 2003-10-09 | Sunol Molecular Corporation | Method of humanizing immune system molecules |
US7357928B2 (en) | 2002-04-08 | 2008-04-15 | University Of Louisville Research Foundation, Inc. | Method for the diagnosis and prognosis of malignant diseases |
US7541150B2 (en) * | 2002-04-08 | 2009-06-02 | University Of Louisville Research Foundation, Inc | Method for the diagnosis and prognosis of malignant diseases |
JP4460443B2 (ja) * | 2002-05-01 | 2010-05-12 | バイエル・シエーリング・ファーマ アクチエンゲゼルシャフト | 抗凝固剤としての新規組織因子標的化された抗体 |
US7579000B2 (en) | 2002-05-01 | 2009-08-25 | Bayer Schering Pharma Ag | Tissue factor targeted antibodies as anticoagulants |
US20050106139A1 (en) * | 2002-10-31 | 2005-05-19 | Ivan Svendsen | Humanized tissue factor antibodies |
US20040198660A1 (en) * | 2002-11-06 | 2004-10-07 | Petersen Lars Christian | Tissue factor antagonist and protein C polypeptide compositions |
EP1587549A2 (en) * | 2003-01-22 | 2005-10-26 | Novo Nordisk A/S | Radiolabelled tissue factor binding agent and the use thereof |
US7425328B2 (en) * | 2003-04-22 | 2008-09-16 | Purdue Pharma L.P. | Tissue factor antibodies and uses thereof |
EP1633309A4 (en) * | 2003-05-30 | 2007-06-13 | Centocor Inc | METHOD FOR INHIBITING TUMOR GROWTH WITH ANTI-TISSUE FACTOR ANTIBODIES |
US7605235B2 (en) | 2003-05-30 | 2009-10-20 | Centocor, Inc. | Anti-tissue factor antibodies and compositions |
US9708410B2 (en) | 2003-05-30 | 2017-07-18 | Janssen Biotech, Inc. | Anti-tissue factor antibodies and compositions |
WO2005004793A2 (en) * | 2003-06-19 | 2005-01-20 | Tanox Inc. | Compositions and methods for treating coagulation related disorders |
EP1667718A4 (en) * | 2003-08-29 | 2007-05-02 | Centocor Inc | METHOD FOR STIMULATING THE SURVIVAL OF A GRAFT WITH ANTI-TISSUE FACTOR ANTIBODY |
RU2006136267A (ru) * | 2004-03-17 | 2008-04-27 | Чирон Корпорейшн (Us) | Лечение тяжелой внебольничной пневмонии путем введения ингибитора пути тканевого фактора (tfpi) |
WO2005118646A2 (en) * | 2004-04-26 | 2005-12-15 | Centocor, Inc. | Epitope directed selection of antibodies to murine tissue factor |
US7790405B2 (en) * | 2004-04-26 | 2010-09-07 | Centocor, Inc. | Solution phase biopanning method using engineered decoy proteins |
US7514539B2 (en) * | 2004-04-26 | 2009-04-07 | Centocor, Inc. | Epitope directed selection of antibodies to murine tissue factor |
JP5017097B2 (ja) * | 2004-04-26 | 2012-09-05 | セントカー・インコーポレーテツド | 設計デコイタンパク質を用いる溶液相バイオパニング方法 |
EP1676574A3 (en) | 2004-12-30 | 2006-07-26 | Johnson & Johnson Vision Care, Inc. | Methods for promoting survival of transplanted tissues and cells |
NZ568762A (en) * | 2005-11-07 | 2011-11-25 | Scripps Research Inst | Use of an inhibitor of tissue factor signaling in the manufacture of a medcament for inhibiting or suppressing tissue factor/tissue factor VIIa signaling involving protease activated receptor 2 in a mammal |
UA109633C2 (uk) | 2008-12-09 | 2015-09-25 | Антитіло людини проти тканинного фактора | |
WO2011062997A2 (en) | 2009-11-17 | 2011-05-26 | Musc Foundation For Research Development | Human monoclonal antibodies to human nucleolin |
EP2380905A1 (en) | 2010-04-19 | 2011-10-26 | Thrombotargets Europe, S.L. | Phospholipid-enriched vesicles bearing tissue factor having haemostatic activities and uses thereof |
CN106084053B (zh) * | 2010-06-15 | 2020-01-17 | 根马布股份公司 | 针对组织因子的人抗体药物缀合物 |
WO2012033518A1 (en) * | 2010-09-09 | 2012-03-15 | The Scripps Research Institute | Methods and compositions for treating metabolic disorders |
US8722044B2 (en) * | 2011-03-15 | 2014-05-13 | Janssen Biotech, Inc. | Human tissue factor antibody and uses thereof |
WO2012167173A1 (en) | 2011-06-02 | 2012-12-06 | The University Of Louisville Research Foundation, Inc. | Anti-nucleolin agent-conjugated nanoparticles |
CN103566378B (zh) * | 2013-09-09 | 2016-09-14 | 南京海智生物工程有限公司 | 基于组织因子的肿瘤核酸疫苗、制备方法及其应用 |
KR102372245B1 (ko) * | 2013-11-21 | 2022-03-08 | 젠맵 에이/에스 | 항체-약물 접합체 동결건조 제제 |
EP3291839A1 (en) | 2015-05-05 | 2018-03-14 | The University of Louisville Research Foundation, Inc. | Anti-nucleolin agent-conjugated nanoparticles as radio-sensitizers and mri and/or x-ray contrast agents |
WO2018208856A1 (en) | 2017-05-08 | 2018-11-15 | Gritstone Oncology, Inc. | Alphavirus neoantigen vectors |
KR101989954B1 (ko) * | 2017-10-16 | 2019-06-17 | 고려대학교 산학협력단 | 돼지 조직인자 세포외 도메인 단백질을 특이적으로 인식하는 단일클론항체 및 이의 용도 |
KR20200118029A (ko) * | 2018-01-04 | 2020-10-14 | 아이코닉 테라퓨틱스, 인코포레이티드 | 항-조직 인자 항체, 항체-약물 결합체, 및 관련 방법 |
TW202110870A (zh) | 2019-05-30 | 2021-03-16 | 美商葛利史東腫瘤科技公司 | 經修飾之腺病毒 |
CN116438308A (zh) | 2020-08-06 | 2023-07-14 | 磨石生物公司 | 多表位疫苗盒 |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4548904A (en) * | 1982-12-03 | 1985-10-22 | Molecular Genetics Research & Development | Protein sequencing method |
IE81149B1 (en) * | 1987-02-12 | 2000-05-03 | Genentech Inc | Methods and deoxyribonucleic acid for the preparation of tissue factor protein |
JPH02501263A (ja) * | 1987-06-12 | 1990-05-10 | マウント サイナイ スクール オブ メディシン オブ ザ シティー ユニバーシティー オブ ニューヨーク | ヒトの組織因子のクローニングと形質発現 |
-
1988
- 1988-03-09 US US07/165,939 patent/US5223427A/en not_active Expired - Lifetime
- 1988-03-29 DE DE3856560T patent/DE3856560T2/de not_active Expired - Lifetime
- 1988-03-29 AT AT88903654T patent/ATE246200T1/de not_active IP Right Cessation
- 1988-03-29 EP EP88903654A patent/EP0309548B1/en not_active Revoked
- 1988-03-29 AU AU16274/88A patent/AU605864B2/en not_active Expired
- 1988-03-29 WO PCT/US1988/000998 patent/WO1988007543A1/en active IP Right Grant
- 1988-03-29 EP EP03077335A patent/EP1364969A3/en not_active Withdrawn
- 1988-03-29 JP JP63503555A patent/JP2809415B2/ja not_active Expired - Lifetime
- 1988-03-30 ES ES8801019A patent/ES2009590A6/es not_active Expired
- 1988-03-30 CA CA000562875A patent/CA1340544C/en not_active Expired - Lifetime
- 1988-03-30 PT PT87138A patent/PT87138B/pt not_active IP Right Cessation
- 1988-11-29 DK DK198806668A patent/DK175703B1/da not_active IP Right Cessation
- 1988-11-29 FI FI885543A patent/FI100184B/fi not_active IP Right Cessation
- 1988-11-29 NO NO885326A patent/NO305211B1/no not_active IP Right Cessation
-
1992
- 1992-04-29 US US07/880,079 patent/US5622931A/en not_active Expired - Lifetime
-
1995
- 1995-09-15 FI FI954347A patent/FI97813C/fi not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
US5223427A (en) | 1993-06-29 |
EP1364969A3 (en) | 2004-12-29 |
NO885326L (no) | 1989-01-30 |
FI97813C (fi) | 1997-02-25 |
FI97813B (fi) | 1996-11-15 |
EP0309548B1 (en) | 2003-07-30 |
FI100184B (fi) | 1997-10-15 |
JPH01503438A (ja) | 1989-11-22 |
ES2009590A6 (es) | 1989-10-01 |
AU1627488A (en) | 1988-11-02 |
US5622931A (en) | 1997-04-22 |
WO1988007543A1 (en) | 1988-10-06 |
DE3856560D1 (de) | 2003-09-04 |
JP2809415B2 (ja) | 1998-10-08 |
NO305211B1 (no) | 1999-04-19 |
EP0309548A4 (en) | 1991-08-07 |
PT87138A (pt) | 1988-04-01 |
FI954347A (fi) | 1995-09-15 |
DE3856560T2 (de) | 2004-08-05 |
PT87138B (pt) | 1992-07-31 |
NO885326D0 (no) | 1988-11-29 |
EP0309548A1 (en) | 1989-04-05 |
AU605864B2 (en) | 1991-01-24 |
EP1364969A2 (en) | 2003-11-26 |
DK175703B1 (da) | 2005-01-24 |
CA1340544C (en) | 1999-05-18 |
ATE246200T1 (de) | 2003-08-15 |
FI954347A0 (fi) | 1995-09-15 |
DK666888A (da) | 1989-01-31 |
FI885543A0 (fi) | 1988-11-29 |
DK666888D0 (da) | 1988-11-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
FI885543A (fi) | Dna-segment, polypeptider och anti-kroppar anslutande till human vaevnadsfaktor. | |
DE3382837D1 (de) | Herstellung von funktionellen, menschlichen Urokinaseproteinen | |
FI873141A (fi) | Daeggdjurs interleukin-4. | |
DE68925226T2 (de) | Monoklonale Antikörper | |
ATE122723T1 (de) | Retinoblastoma-genprodukt-antikörper und deren verwendungen. | |
PT676413E (pt) | Proteina de ligacao a interferoes alfa/beta, sua preparacao e utilizacao | |
ES2056872T3 (es) | Proteina pp4-x anticoagulante, su preparacion y empleo. | |
ATE407944T1 (de) | Mit trp-proteinen verwandtes protein mtr1 und dieses codierende dna-sequenz | |
ATE229983T1 (de) | Maspin- ein neues serpin mit tumor unterdrückender aktivität | |
DK0487229T3 (da) | DNA, der koder for et protein, som binder til enhanceren for alfa-føtoproteingenet | |
DE68917520T2 (de) | Verfahren und Systeme zur Herstellung von HIV-Antigenen. | |
NO173340C (no) | Humant protein C antistoff |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG | Patent granted |
Owner name: SCRIPPS CLINIC AND RESEARCH FOUNDATION |
|
MA | Patent expired |